Progenitor is a pioneering regenerative medicine company that develops drugs to regenerate specific tissues of the human body in response to injury, disease or aging. We focus on helping the body cure itself, rather than treating the symptoms of diseases.
Our scientists are experienced stem cell biologists and drug hunters, recruited from the world’s leading stem cell research institutes. They use award-winning combinatorial technologies developed specifically for stem cell research, to perform very large numbers of experiments in parallel.
We are focusing initially on three therapeutic programmes, to address diseases that affect millions of patients worldwide.